GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $0.265 $0.480 Friday, 19th Apr 2024 WINT stock ended at $0.342. This is 0.589% more than the trading day before Thursday, 18th Apr 2024. During the day the stock fluctuated 9.06% from a day low at $0.330 to a day high of $0.360.
90 days $0.265 $0.532
52 weeks $0.265 $2.47

Historical Windtree Therapeutics Inc prices

Date Open High Low Close Volume
2023-05-26 $1.27 $1.30 $1.23 $1.25 212 031
2023-05-25 $1.36 $1.40 $1.29 $1.30 324 386
2023-05-24 $1.45 $1.45 $1.37 $1.39 230 439
2023-05-23 $1.44 $1.50 $1.44 $1.46 166 092
2023-05-22 $1.46 $1.49 $1.42 $1.44 223 628
2023-05-19 $1.47 $1.51 $1.46 $1.49 119 690
2023-05-18 $1.49 $1.55 $1.41 $1.51 389 014
2023-05-17 $1.42 $1.53 $1.38 $1.49 344 698
2023-05-16 $1.46 $1.49 $1.39 $1.42 288 322
2023-05-15 $1.55 $1.56 $1.46 $1.49 268 998
2023-05-12 $1.62 $1.62 $1.52 $1.55 309 365
2023-05-11 $1.58 $1.70 $1.47 $1.63 495 734
2023-05-10 $1.71 $1.71 $1.57 $1.61 373 866
2023-05-09 $1.63 $1.85 $1.57 $1.72 991 394
2023-05-08 $1.61 $1.70 $1.51 $1.65 671 129
2023-05-05 $1.54 $1.63 $1.50 $1.61 940 649
2023-05-04 $1.55 $1.60 $1.49 $1.53 624 109
2023-05-03 $1.50 $1.66 $1.36 $1.60 2 104 028
2023-05-02 $1.49 $1.49 $1.36 $1.36 358 267
2023-05-01 $1.52 $1.54 $1.45 $1.47 490 751
2023-04-28 $1.64 $1.68 $1.58 $1.64 379 847
2023-04-27 $1.82 $1.82 $1.61 $1.69 856 389
2023-04-26 $1.81 $1.81 $1.57 $1.76 945 554
2023-04-25 $2.16 $2.16 $1.84 $1.86 1 183 748
2023-04-24 $2.21 $2.23 $2.01 $2.12 1 221 555
Click to get the best stock tips daily for free!

About Windtree Therapeutics Inc

Windtree Therapeutics Windtree Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of acute cardiovascular and secondarily in acute pulmonary diseases. The company's lead development programs include istaroxime, which is in Phase IIb clinical trial for the treatment of acute decompensated heart failure, as well as in Phase IIa clinical trial for the treatment of early cardiogenic shock; AEROSURF,... WINT Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT